Journey Medical Corporation (NASDAQ: DERM)
$6.05
+0.1400 ( +2.37% ) 46.4K
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
Market Data
Open
$6.05
Previous close
$5.91
Volume
46.4K
Market cap
$116.28M
Day range
$5.79 - $6.10
52 week range
$1.60 - $8.11
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Dec 08, 2023 |
8-k | 8K-related | 12 | Dec 08, 2023 |
4 | Insider transactions | 1 | Nov 29, 2023 |
10-q | Quarterly Reports | 90 | Nov 13, 2023 |
8-k | 8K-related | 14 | Nov 07, 2023 |
4 | Insider transactions | 1 | Oct 17, 2023 |
4 | Insider transactions | 1 | Oct 10, 2023 |
8-k | 8K-related | 12 | Sep 26, 2023 |
4 | Insider transactions | 1 | Sep 25, 2023 |
8-k | 8K-related | 12 | Sep 19, 2023 |